Systematic review finds first FDA-approved CRISPR therapy and broader clinical trial exploration
First CRISPR gene therapy approved for blood disorders, with broader research underway
A systematic review of clinical trials registered at clinicaltrials.gov found the first CRISPR-Cas9 therapy obtained FDA approval in late 20…
The first CRISPR gene therapy is approved for sickle-cell anemia and β-thalassemia, with ongoing trials exploring its use for cancer and inf…
Report examines use of recommended health care measures for sickle cell anemia complications in youth
Report examines use of preventive care for children with sickle cell anemia
A report describes the use of recommended health care measures to prevent complications of sickle cell anemia in children and adolescents in…
A new report looked at how children and adolescents with sickle cell anemia in the U.S. use recommended health care measures to prevent comp…